Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      CM Rawat meets Israeli delegation: Uttarakhand likely to get algae, cannabis farms

      CM Rawat meets Israeli delegation: Uttarakhand likely to get algae, cannabis farms

      Farhat Nasim27 Dec 2018 2:46 PM IST
      According to a press release by the government, Puremagics Ltd, an Israeli firm specialising in biotechnology, intends to produce Haematococcus...
      Sun Pharma arm gets relief from US court in patent infringement case

      Sun Pharma arm gets relief from US court in patent infringement case

      Farhat Nasim27 Dec 2018 11:12 AM IST
      Earlier this year, DUSA, which is wholly-owned by Sun Pharma, filed a lawsuit against the Biofrontera defendants in the US District Court for the...
      Dr Reddys launches Sevelamer Carbonate in the US market

      Dr Reddy's launches Sevelamer Carbonate in the US market

      Farhat Nasim27 Dec 2018 9:30 AM IST
      The newly launched Sevelamer Carbonate is in the strengths of 0.8 g and 2.4 g packets and is a therapeutic equivalent generic version of Renvela...
      No issue of impurities in Losartan in India: Torrent Pharma

      No issue of impurities in Losartan in India: Torrent Pharma

      Farhat Nasim26 Dec 2018 2:58 PM IST
      When questioned about the recalling of Losartan tablets sold in India, Jayesh Desai, Executive Director told IANS, “Currently, we do not have this...
      Indias richest saw Rs 2100 crore vanish in 2018, Shanghvi lost Rs 460 crore: Bloomberg

      India's richest saw Rs 2100 crore vanish in 2018, Shanghvi lost Rs 460 crore: Bloomberg

      Farhat Nasim24 Dec 2018 1:56 PM IST
      India’s 23 richest people, meanwhile, saw $21 billion(Rs 2100 crore) vanish. Lakshmi Mittal, who controls the world’s largest steelmaker, led the way,...
      CDSCO increases licence fee for various application procedures

      CDSCO increases licence fee for various application procedures

      Farhat Nasim23 Dec 2018 10:05 AM IST
      New Delhi: Through a recent office memorandum, the Central Drugs Standard Control Organization(CDSCO) announced the Implementation of increase in...
      Torrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDA

      Torrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDA

      Farhat Nasim23 Dec 2018 9:45 AM IST
      New Delhi: Indian pharmaceutical major, Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets in the US market...
      Another trouble for J&J: CDSCO seize samples of baby products for testing

      Another trouble for J&J: CDSCO seize samples of baby products for testing

      Farhat Nasim22 Dec 2018 12:14 PM IST
      The action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
      Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

      Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

      Farhat Nasim22 Dec 2018 11:02 AM IST
      Markets regulator Sebi Friday directed Fortis Healthcare and Fortis Hospitals to take necessary steps to recover Rs 403 crore, along with interest,...
      Novartis appoints Susanne Schaffert as new CEO of Oncology Business Unit

      Novartis appoints Susanne Schaffert as new CEO of Oncology Business Unit

      Farhat Nasim22 Dec 2018 9:35 AM IST
      Susanne Schaffert will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019.New Delhi: Swiss pharma giant...
      Sun Pharma arm gets USFDA nod for Elepsia XR, an antiepileptic drug

      Sun Pharma arm gets USFDA nod for Elepsia XR, an antiepileptic drug

      Farhat Nasim22 Dec 2018 9:30 AM IST
      The United States Food and Drug Administration (USFDA) has granted approval for the New Drug Application to a wholly-owned subsidiary of Sun Pharma...
      Bristol-Myers gets more than Rs 1000 crore offer from Taisho Pharma

      Bristol-Myers gets more than Rs 1000 crore offer from Taisho Pharma

      Farhat Nasim22 Dec 2018 9:15 AM IST
      Upon exercise of the put option, Taisho would acquire UPSA as well as Bristol-Myers Squibb's assets and liabilities relating to the UPSA product...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok